Dataset Information


Blood RNA-seq data from individuals during the UK Covid-19 lockdown, spanning sequential weeks from first PCR-confirmed SARS-CoV-2 infection, used to evaluate blood transcriptomic signatures of viral infection and identify host-response biomarkers of early SARS-CoV-2 infection

ABSTRACT: Healthcare workers were recruited at St Bartholomew’s Hospital, London, UK in the week of lockdown in the United Kingdom (between 23rd and 31st March 2020). Participants underwent weekly evaluation using a questionnaire and biological sample collection (including serological assays) for up to 16 weeks when attending for work and self-declared as fit to attend work at each visit, with further follow up samples collected at 24 weeks. Blood RNA sequencing data was to be used to identify host-response biomarkers of early SARS-CoV-2 infection, to evaluate existing blood transcriptomic signatures of viral infection, and to describe the underlying biology during SARS-CoV-2 infection. This submission includes a total of 172 blood RNA samples from 99 participants. Of these, 114 samples (including 16 convalescent samples collected 6 months after infection) were obtained from 41 SARS-CoV-2 cases, with the remaining 58 from uninfected controls. Participants with available blood RNA samples who had PCR-confirmed SARS-CoV-2 infection during follow-up were included as ‘cases’. Those without evidence of SARS-CoV-2 infection on nasopharyngeal swabs and who remained seronegative by both Euroimmun anti S1 spike protein and Roche anti nucleocapsid protein throughout follow-up were included as uninfected controls. ‘Cases’ include all available RNA samples, including convalescent samples at week 24 of follow-up for a subset of participants. For uninfected controls, we included baseline samples only. Sample class denotes weekly interval to positive SARS-CoV-2 PCR; non-infected controls (NIC); convalescent samples (Conv)_.

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Homo Sapiens

DISEASE(S): Sars-cov-2 Infection,Normal

SUBMITTER: Joshua Rosenheim  

PROVIDER: E-MTAB-10022 | ArrayExpress | 2021-07-07


altmetric image


<h4>Background</h4>We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing.<h4>Methods</h4>We did a nested case-control diagnostic accuracy study among a prospect  ...[more]

Similar Datasets

| E-MTAB-10022 | BioStudies
| S-EPMC8016542 | BioStudies
| S-EPMC7975276 | BioStudies
| S-EPMC8126762 | BioStudies
| S-EPMC8557935 | BioStudies
| S-EPMC8494997 | BioStudies
| S-EPMC8689778 | BioStudies
| S-EPMC8420579 | BioStudies
| S-EPMC7781328 | BioStudies
| S-EPMC8195007 | BioStudies